Corona Remedies Ltd (CORONA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039887, "name": "Corona Remedies", "stock_name": "Corona Remedies", "full_name": "Corona Remedies Ltd", "name_url": "stocks-analysis/corona-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,110.20", "chg": -54.15, "chgp": "-2.5%", "dir": -1, "prev_price": "2,164.35", "mcapval": "13,239.00 Cr", "mcap": "Small Cap", "scripcode": 544644, "symbol": "CORONA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE02ZQ01018", "curr_date": "Sep 24, 03:30 PM", "curr_time": "21:29 PM", "last_traded_at": "Sep 24, 03:30 PM IST", "bse_nse_vol": "46.8 k", "exc_status": "Active", "traded_date": "Sep 24, 2026", "traded_date_str": "2026 09 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Corona Remedies Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-is-rated-buy-by-marketsmojo-4203505", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_mojoScore_4203505.png", "date": "2026-09-24 10:10:56", "description": "Corona Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Corona Remedies Ltd Declines 1.68% Despite Technical Strength: 4 Key Factors This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-declines-168-despite-technical-strength-4-key-factors-this-week-4197748", "imagepath": "", "date": "2026-09-19 09:00:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> New 52-week and all-time high at Rs.2,285</p>\n <p><strong>15 Sep:</strong> Technical momentum shifts to bullish</p>\n <p><strong>16 Sep:</strong> Mild technical pullback amid strong YTD gains</p>\n <p><strong>18 Sep:</strong> Week closes at Rs.2,198.75 (-1.68%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,236.30</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,198.75</div><div class=\"stat-change negative\"..." }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Strong Year-to-Date Gains", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-strong-year-to-date-gains-4194382", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_technicaldot_4194382.png", "date": "2026-09-16 08:10:34", "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a nuanced shift in its technical momentum despite posting robust year-to-date returns of 60.3%, significantly outperforming the Sensex’s negative 13.2% over the same period. Recent technical indicators reveal a transition from a bullish to a mildly bullish trend, signalling a potential consolidation phase after a strong rally." }, { "title": "Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2285", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-new-52-week-high-at-rs-2285-4193488", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_priceRelatedfactors_4193488.png", "date": "2026-09-15 10:21:45", "description": "With a decisive break above its previous peaks, Corona Remedies Ltd reached a new 52-week and all-time high of Rs 2285 on 15 Sep 2026, marking a significant milestone in its price momentum. This surge comes after a sustained five-day rally that has propelled the stock up by 7.88%, outpacing its sector by 0.91% on the day." }, { "title": "Corona Remedies Ltd Hits All-Time High of Rs 2,285 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-stock-hits-all-time-high-at-rs-2285-4193443", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_priceRelatedfactors_4193443.png", "date": "2026-09-15 10:09:34", "description": "" }, { "title": "Corona Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-signal-bullish-outlook-4192840", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_technicaldot_4192840.png", "date": "2026-09-15 08:04:25", "description": "Corona Remedies Ltd has exhibited a marked shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of late July 2026. This change is supported by a confluence of positive signals from key technical indicators including MACD, Bollinger Bands, and On-Balance Volume (OBV), suggesting a robust upward trajectory for the small-cap pharmaceutical player amid a challenging broader market environment." }, { "title": "Corona Remedies Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-is-rated-buy-4192100", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_mojoScore_4192100.png", "date": "2026-09-13 10:10:04", "description": "Corona Remedies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Corona Remedies Ltd Surges 7.06% to Day's High of Rs 2244.25 — Outperforms Sector by 7.2 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-intraday-high-with-706-surge-on-9-september-2026-4187978", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_priceRelatedfactors_4187978.png", "date": "2026-09-09 10:11:43", "description": "While the Sensex declined by 0.83% on 09 Sep 2026, Corona Remedies Ltd surged 7.06%, touching an intraday high of Rs 2244.25. This 7.2-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally amid a broadly weak market environment." }, { "title": "Corona Remedies Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-is-rated-buy-4179374", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/CoronaRemediesL_mojoScore_4179374.png", "date": "2026-09-02 10:10:49", "description": "Corona Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 September 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market standing." } ], "total": 73, "sid": "10039887", "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887" }, "announcements": [ { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "19-Sep-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "19-Sep-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sepia Investments Ltd Sage Investment Trust & Anchor Partners", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "18-Sep-2026", "details": "Intimation of participation in Analyst / Investor meet", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26", "dt": "2026-06-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Sep: New 52-week and all-time high at Rs.2,285

15 Sep: Technical momentum shifts to bullish

16 Sep: Mild technical pullback amid strong YTD gains

18 Sep: Week closes at Rs.2,198.75 (-1.68%)

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Amid Strong Year-to-Date Gains

2026-09-16 08:10:34

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a nuanced shift in its technical momentum despite posting robust year-to-date returns of 60.3%, significantly outperforming the Sensex’s negative 13.2% over the same period. Recent technical indicators reveal a transition from a bullish to a mildly bullish trend, signalling a potential consolidation phase after a strong rally.

Read full news article

Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2285

2026-09-15 10:21:45

With a decisive break above its previous peaks, Corona Remedies Ltd reached a new 52-week and all-time high of Rs 2285 on 15 Sep 2026, marking a significant milestone in its price momentum. This surge comes after a sustained five-day rally that has propelled the stock up by 7.88%, outpacing its sector by 0.91% on the day.

Read full news article

Corona Remedies Ltd Hits All-Time High of Rs 2,285 as Momentum Builds Across Timeframes

2026-09-15 10:09:34

Read full news article

Corona Remedies Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-15 08:04:25

Corona Remedies Ltd has exhibited a marked shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of late July 2026. This change is supported by a confluence of positive signals from key technical indicators including MACD, Bollinger Bands, and On-Balance Volume (OBV), suggesting a robust upward trajectory for the small-cap pharmaceutical player amid a challenging broader market environment.

Read full news article

Corona Remedies Ltd is Rated Buy

2026-09-13 10:10:04

Corona Remedies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Corona Remedies Ltd Surges 7.06% to Day's High of Rs 2244.25 — Outperforms Sector by 7.2 Percentage Points

2026-09-09 10:11:43

While the Sensex declined by 0.83% on 09 Sep 2026, Corona Remedies Ltd surged 7.06%, touching an intraday high of Rs 2244.25. This 7.2-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally amid a broadly weak market environment.

Read full news article

Corona Remedies Ltd is Rated Buy

2026-09-02 10:10:49

Corona Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 September 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article